James R. Kasinger - Dec 3, 2021 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Signature
/s/ Michael Esposito, attorney-in-fact
Stock symbol
CRSP
Transactions as of
Dec 3, 2021
Transactions value $
-$435,979
Form type
4
Date filed
12/7/2021, 07:00 PM
Previous filing
Dec 3, 2021
Next filing
Feb 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRSP Common Shares Options Exercise +13.3K +36.52% 49.8K Dec 3, 2021 Direct F1, F2
transaction CRSP Common Shares Tax liability -$436K -6.3K -12.65% $69.17 43.5K Dec 6, 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRSP Restricted Stock Units Options Exercise +13.3K 6.67K Dec 3, 2021 Common Shares 13.3K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022.
F2 Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
F3 On December 3, 2019, the reporting person was granted 20,000 restricted stock units. On December 3, 2021, 13,333 restricted stock units vested. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.